| P50 | author | Benjamin Drukarch | Q72984594 |
| P2093 | author name string | Guojun Bu | |
| | Annemieke J M Rozemuller | |
| | Elise S Van Haastert | |
| | Jeroen J M Hoozemans | |
| | John G J M Bol | |
| | Micha M M Wilhelmus | |
| P2860 | cites work | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease | Q22248091 |
| | 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein | Q24568257 |
| | Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy | Q24604376 |
| | Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 |
| | Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 |
| | Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain | Q28291271 |
| | Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 |
| | Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity | Q34210006 |
| | The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family | Q34387393 |
| | LRP and Alzheimer's disease | Q36164972 |
| | Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells | Q36202900 |
| | Parkinson's disease: premotor clinico-pathological correlations | Q36611544 |
| | A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders | Q37249041 |
| | Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake | Q37446156 |
| | Alpha-synuclein, lipids and Parkinson's disease | Q37767943 |
| | Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperone | Q38346722 |
| | Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease | Q46761473 |
| | Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning | Q48668350 |
| | Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease | Q48692087 |
| | Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease | Q48795523 |
| | Apolipoprotein E genotype regulates amyloid-beta cytotoxicity. | Q48939701 |
| | A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. | Q53292476 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 2152-2156 | |
| P577 | publication date | 2011-09-09 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis | |
| P478 | volume | 179 | |